|
|
|
|
|
6. Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutationAjda Anžič Drofenik, Matjaž Vrtovec, Mojca Božič, Matjaž Sever, Irena Preložnik-Zupan, Nataša Kejžar, Aleš Blinc, 2020, izvirni znanstveni članek Ključne besede: essential thrombocythemia, JAK2 V617F mutation, arterial stiffness, coronary calcium, cardiovascular risk
Celotno besedilo (datoteka, 613,23 KB) Gradivo ima več datotek! Več... |
7. The impact of SARS-CoV-2 primary vaccination in a cohort of patients hospitalized for acute COVID-19 during Delta variant predominanceDaša Stupica, Stefan Collinet-Adler, Nataša Kejžar, Zala Jagodic, Mario Poljak, Mirijam Nahtigal Klevišar, 2022, izvirni znanstveni članek Ključne besede: COVID-19 vaccine, vaccine breakthrough, vaccination impact, COVID-19 outcome
Celotno besedilo (datoteka, 709,47 KB) Gradivo ima več datotek! Več... |
8. Survival of castration-resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56$^{bright}$CD16$^−$ natural killer cellsHelena Haque Chowdhury, Simon Hawlina, Mateja Gabrijel, Saša Trkov, Marko Kreft, Gordan Lenart, Marko Cukjati, Andreja Nataša Kopitar, Nataša Kejžar, Alojz Ihan, Luka Ležaič, Marko Grmek, Andrej Kmetec, Matjaž Jeras, Robert Zorec, 2021, kratki znanstveni prispevek Ključne besede: prostate cancer, natural killer cells, decreasing resection rates
Celotno besedilo (datoteka, 956,28 KB) Gradivo ima več datotek! Več... |
9. Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndromeEmil Pal, Miša Korva, Katarina Resman Rus, Nataša Kejžar, Petra Bogovič, Franc Strle, Tatjana Avšič-Županc, 2018, izvirni znanstveni članek Ključne besede: hemorrhagic fever, vascular endothelial growth factor, soluble receptor
Celotno besedilo (datoteka, 968,54 KB) Gradivo ima več datotek! Več... |
|
